Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 198-207, September 2007

Atomic force microscopy evaluation of the effects of a novel antimicrobial multimeric peptide on Pseudomonas aeruginosa

  • Greta Rossetto, MS

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • ,
  • Paolo Bergese, PhD

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • ,
  • Paolo Colombi, PhD

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • Corresponding Author InformationCorresponding author. INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Via Branze 38, 25123 Brescia, Italy.
    • ,
  • Laura E. Depero

      Affiliations

    • INSTM and Laboratorio di Chimica per le Tecnologie, Università di Brescia, Brescia, Italy
    • ,
  • Andrea Giuliani, PhD

      Affiliations

    • SpiderBiotech S.r.l., Colleretto Giacosa, Torino, Italy
    • ,
  • Silvia F. Nicoletto, MS

      Affiliations

    • SpiderBiotech S.r.l., Colleretto Giacosa, Torino, Italy
    • ,
  • Giovanna Pirri, MD, MS

      Affiliations

    • SpiderBiotech S.r.l., Colleretto Giacosa, Torino, Italy

Received 27 April 2007; accepted 22 June 2007. published online 16 August 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The authors declare competing financial interests. A. Giuliani is an executive board member and minor shareholder of SpiderBiotech which is developing antimicrobial peptides. G. Pirri is head of research and minor shareholder of SpiderBiotech.

PII: S1549-9634(07)00091-3

doi:10.1016/j.nano.2007.06.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 198-207, September 2007

Article Tools

* Image Usage & Resolution